These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 30245648)

  • 1. Psychedelics, Meditation, and Self-Consciousness.
    Millière R; Carhart-Harris RL; Roseman L; Trautwein FM; Berkovich-Ohana A
    Front Psychol; 2018; 9():1475. PubMed ID: 30245648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linkages between Psychedelics and Meditation in a Population-Based Sample in the United States.
    Simonsson O; Goldberg SB
    J Psychoactive Drugs; 2023; 55(1):11-18. PubMed ID: 35000559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects.
    Smigielski L; Scheidegger M; Kometer M; Vollenweider FX
    Neuroimage; 2019 Aug; 196():207-215. PubMed ID: 30965131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Looking for the Self: Phenomenology, Neurophysiology and Philosophical Significance of Drug-induced Ego Dissolution.
    Millière R
    Front Hum Neurosci; 2017; 11():245. PubMed ID: 28588463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mindfulness meditation and psychedelics: potential synergies and commonalities.
    Holas P; Kamińska J
    Pharmacol Rep; 2023 Dec; 75(6):1398-1409. PubMed ID: 37926796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The bodily self from psychosis to psychedelics.
    Harduf A; Panishev G; Harel EV; Stern Y; Salomon R
    Sci Rep; 2023 Dec; 13(1):21209. PubMed ID: 38040825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenomenology, Structure, and Dynamic of Psychedelic States.
    Preller KH; Vollenweider FX
    Curr Top Behav Neurosci; 2018; 36():221-256. PubMed ID: 28025814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychedelics and Consciousness: Distinctions, Demarcations, and Opportunities.
    Yaden DB; Johnson MW; Griffiths RR; Doss MK; Garcia-Romeu A; Nayak S; Gukasyan N; Mathur BN; Barrett FS
    Int J Neuropsychopharmacol; 2021 Aug; 24(8):615-623. PubMed ID: 33987652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychedelics, entropic brain theory, and the taxonomy of conscious states: a summary of debates and perspectives.
    Rankaduwa S; Owen AM
    Neurosci Conscious; 2023; 2023(1):niad001. PubMed ID: 37025356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ego-Dissolution and Psychedelics: Validation of the Ego-Dissolution Inventory (EDI).
    Nour MM; Evans L; Nutt D; Carhart-Harris RL
    Front Hum Neurosci; 2016; 10():269. PubMed ID: 27378878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classic psychedelic use and current meditation practice.
    Simonsson C; Chambers R; Hendricks PS; Goldberg SB; Osika W; Schlosser M; Ryde A; Christersson E; Simonsson O
    Mindfulness (N Y); 2023 Apr; 14(4):763-768. PubMed ID: 37693239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dreams and Psychedelics: Neurophenomenological Comparison and Therapeutic Implications.
    Kraehenmann R
    Curr Neuropharmacol; 2017; 15(7):1032-1042. PubMed ID: 28625125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dimensions of consciousness and the psychedelic state.
    Bayne T; Carter O
    Neurosci Conscious; 2018; 2018(1):niy008. PubMed ID: 30254752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenomenological assessment of psychedelics induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI).
    Dworatzyk K; Jansen T; Schmidt TT
    PLoS One; 2022; 17(3):e0264927. PubMed ID: 35294453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Psychedelic Experiences: Phenomenology, Therapeutic Potentials and Explanatory Models].
    Chernoff T; Kliger B; Venturini DH
    Vertex; 2023 Jul; 34(160, abr.-jun.):100-112. PubMed ID: 37562384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naturalistic use of psychedelics is related to emotional reactivity and self-consciousness: The mediating role of ego-dissolution and mystical experiences.
    Orłowski P; Ruban A; Szczypiński J; Hobot J; Bielecki M; Bola M
    J Psychopharmacol; 2022 Aug; 36(8):987-1000. PubMed ID: 35475373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A neurophenomenological approach to non-ordinary states of consciousness: hypnosis, meditation, and psychedelics.
    Timmermann C; Bauer PR; Gosseries O; Vanhaudenhuyse A; Vollenweider F; Laureys S; Singer T; ; Antonova E; Lutz A
    Trends Cogn Sci; 2023 Feb; 27(2):139-159. PubMed ID: 36566091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Language as a Window Into the Altered State of Consciousness Elicited by Psychedelic Drugs.
    Tagliazucchi E
    Front Pharmacol; 2022; 13():812227. PubMed ID: 35392561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the acute subjective psychedelic experience: A review of patient-reported outcome measures in clinical research on classical psychedelics.
    Hovmand OR; Poulsen ED; Arnfred S
    J Psychopharmacol; 2024 Jan; 38(1):19-32. PubMed ID: 37969069
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 28.